文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

儿童急性呼吸窘迫综合征死亡预测模型:PARDIE研究

Predicting Mortality in Children With Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论基于儿童急性呼吸窘迫综合征发病第0天 readily available 变量构建的死亡预测模型,在推导队列和验证队列中均显示出良好区分度,可用于临床试验风险分层。

该研究基于多国儿童急性呼吸窘迫综合征发病率与流行病学研究(PARDIE)的辅助研究,纳入624例推导队列和640例验证队列受试者,旨在开发并验证儿童急性呼吸窘迫综合征死亡预测模型。全队列模型包含免疫抑制状态、儿童 Logistic 器官功能障碍2评分、第0天血管活性-正性肌力评分和液体平衡,以及儿童急性呼吸窘迫综合征发病后6小时PaO2/FIO2,推导队列AUC为0.82,验证队列中插管患儿模型AUC≥0.85但校准度差,排除神经性死亡后校准度完美。模型还可对28天无呼吸机天数进行分层,作者认为可用于临床试验风险分层。

要点

  • 推导队列624例、验证队列640例插管儿童ARDS患者,模型变量包括免疫抑制状态、PELOD-2评分、第0天VIS和液体平衡、发病后6小时PaO2/FIO2。
  • 全队列模型推导队列AUC 0.82,内部验证区分度和校准度良好;排除神经性死亡、插管亚组模型AUC均≥0.84。
  • 验证队列中插管ARDS模型(含和不含神经性死亡)AUC均≥0.85,但校准度差;修订后排除神经性死亡模型校准度完美,含神经性死亡模型仍校准不良。
  • 模型在推导和验证队列中均可对28天无呼吸机天数进行分层。
  • 作者认为该模型使用发病第0天易得变量,优于疾病严重程度评分,可辅助临床试验风险分层。

适用人群与场景

  • 推导队列来自全球100个中心的儿童急性呼吸窘迫综合征患者,共624例;验证队列为费城儿童医院插管儿童急性呼吸窘迫综合征患者,共640例。
  • 研究纳入儿童急性呼吸窘迫综合征患者,亚组分析包括插管受试者和排除神经性死亡受试者。

研究设计与关键结果

  • 研究为多国儿童急性呼吸窘迫综合征发病率与流行病学研究(PARDIE)的计划性辅助研究(版本1),推导队列624例,验证队列640例,无干预。
  • 全队列死亡预测模型包含免疫抑制状态、儿童Logistic器官功能障碍2评分、第0天血管活性-正性肌力评分和液体平衡、儿童急性呼吸窘迫综合征发病后6小时PaO2/FIO2,推导队列AUC 0.82,校准度和内部验证良好。
  • 排除神经性死亡、插管受试者、插管且排除神经性死亡亚组模型推导队列AUC均≥0.84,校准度良好。
  • 验证队列中插管儿童急性呼吸窘迫综合征模型(含和不含神经性死亡)AUC均≥0.85,但校准度差;修订后,所有插管受试者模型仍校准不良,排除神经性死亡模型校准度完美。
  • 模型在推导和验证队列中均可对28天无呼吸机天数进行分层。

证据类型、等级与局限

  • 证据类型:多中心推导与外部验证的预测模型研究(基于PARDIE辅助研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该模型使用儿童急性呼吸窘迫综合征发病第0天易得变量,优于疾病严重程度评分,可辅助临床试验风险分层。
  • 验证队列中插管儿童急性呼吸窘迫综合征模型(含和不含神经性死亡)区分度优秀(AUC均≥0.85)但校准度差;修订后排除神经性死亡模型校准度完美,含神经性死亡模型仍校准不良。
  • 模型可对28天无呼吸机天数进行分层,作者认为可用于复合结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Pediatric acute respiratory distress syndrome is heterogeneous, with a paucity of risk stratification tools to assist with trial design. We aimed to develop and validate mortality prediction models for patients with pediatric acute respiratory distress syndrome.

DESIGN: Leveraging additional data collection from a preplanned ancillary study (Version 1) of the multinational Pediatric Acute Respiratory Distress syndrome Incidence and Epidemiology study, we identified predictors of mortality. Separate models were built for the entire Version 1 cohort, for the cohort excluding neurologic deaths, for intubated subjects, and for intubated subjects excluding neurologic deaths. Models were externally validated in a cohort of intubated pediatric acute respiratory distress syndrome patients from the Children's Hospital of Philadelphia.

SETTING: The derivation cohort represented 100 centers worldwide; the validation cohort was from Children's Hospital of Philadelphia.

PATIENTS: There were 624 and 640 subjects in the derivation and validation cohorts, respectively.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The model for the full cohort included immunocompromised status, Pediatric Logistic Organ Dysfunction 2 score, day 0 vasopressor-inotrope score and fluid balance, and PaO2/FIO2 6 hours after pediatric acute respiratory distress syndrome onset. This model had good discrimination (area under the receiver operating characteristic curve 0.82), calibration, and internal validation. Models excluding neurologic deaths, for intubated subjects, and for intubated subjects excluding neurologic deaths also demonstrated good discrimination (all area under the receiver operating characteristic curve ≥ 0.84) and calibration. In the validation cohort, models for intubated pediatric acute respiratory distress syndrome (including and excluding neurologic deaths) had excellent discrimination (both area under the receiver operating characteristic curve ≥ 0.85), but poor calibration. After revision, the model for all intubated subjects remained miscalibrated, whereas the model excluding neurologic deaths showed perfect calibration. Mortality models also stratified ventilator-free days at 28 days in both derivation and validation cohorts.

CONCLUSIONS: We describe predictive models for mortality in pediatric acute respiratory distress syndrome using readily available variables from day 0 of pediatric acute respiratory distress syndrome which outperform severity of illness scores and which demonstrate utility for composite outcomes such as ventilator-free days. Models can assist with risk stratification for clinical trials.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Yehya N, Harhay MO, Klein MJ, et al. Predicting Mortality in Children With Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study. Crit Care Med. 2020. PMID: 32271186. doi:10.1097/CCM.0000000000004345

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。